Research Topics
Genomes and Genes
| Sholom WacholderSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Precursors in cancer epidemiology: aligning definition and functionSholom Wacholder
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, 6120 Executive Blvd, Room 5050, National Cancer Institute, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 22:521-7. 2013....
Invited commentary: more surprises from a gene desertSholom Wacholder
National Institutes of Health National Cancer Institute, Rockville, MD 20852, USA
Am J Epidemiol 175:488-91. 2012....
A population-based cross-sectional study of age-specific risk factors for high risk human papillomavirus prevalence in rural NigeriaMegan A Clarke
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
Infect Agent Cancer 6:12. 2011..abstract:..
Multi-center feasibility study evaluating recruitment, variability in risk factors and biomarkers for a diet and cancer cohort in IndiaRashmi Sinha
National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD, USA
BMC Public Health 11:405. 2011..The aim of this feasibility study was to evaluate whether a diet-focused cohort study of cancer could be established in India, providing insight into potentially unique diet and lifestyle exposures...
Performance of common genetic variants in breast-cancer risk modelsSholom Wacholder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS 5050, MSC 7244, Bethesda, MD 20892, USA
N Engl J Med 362:986-93. 2010..Genomewide association studies have identified multiple genetic variants associated with breast cancer. The extent to which these variants add to existing risk-assessment models is unknown...
Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trialsSholom Wacholder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rockville, MD 20852, USA
BMJ 340:c712. 2010..To assess whether vaccination against human papillomavirus (HPV) increases the risk of miscarriage...
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infectionsAna Cecilia Rodriguez
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS, Rm 5032, Rockville, MD 20852, USA
J Natl Cancer Inst 100:513-7. 2008..These findings suggest that the medical community should emphasize persistence of cervical HPV infection, not single-time detection of HPV, in management strategies and health messages...
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancerSophia S Wang
Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm 5104, Rockville, MD 20852 7234, USA
J Infect Dis 199:20-30. 2009..We examined host genetic factors to identify those more common in individuals whose human papillomavirus (HPV) infections were most likely to persist and progress to cervical intraepithelial neoplasia grade 3 (CIN3) and cancer...
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinantsSophia S Wang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, Room 5104, Rockville, MD 20854 7234, USA
Cancer Epidemiol Biomarkers Prev 18:113-20. 2009..Investigations on the molecular distinctions along the disease continuum of cervical pathogenesis by HPV type are needed...
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Gilles Thomas
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Nat Genet 41:579-84. 2009..1 (rs999737; P = 1.74 x 10(-7)) localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway. We also confirmed associations with loci on chromosomes 2q35, 5p12, 5q11.2, 8q24, 10q26 and 16q12.1...
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA
J Natl Cancer Inst 102:1794-804. 2010..In a large prospective cohort, we assessed the role of C trachomatis in cervical premalignancy and addressed confounding by HPV...
Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisitedJill Koshiol
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7248, USA
Cancer Epidemiol Biomarkers Prev 18:1631-7. 2009..Although genetic variation in TP53 might affect the natural history of HPV and cervical cancer, further work is needed to elucidate the possible mechanism...
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancerMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America
PLoS ONE 7:e33619. 2012..Host genetic factors might affect the risk of progression from infection with carcinogenic human papillomavirus (HPV), the etiologic agent for cervical cancer, to persistent HPV infection, and hence to cervical precancer and cancer...
Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopyCarolina Porras
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Int J Cancer 130:1879-87. 2012..Our data support the need for a nonvisual diagnostic method to guide management and treatment of HPV-positive women...
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practiceMichelle J Khan
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Rm. 7074, Rockville, MD 20852, USA
J Natl Cancer Inst 97:1072-9. 2005..CONCLUSIONS: HPV screening that distinguishes HPV16 and HPV18 from other oncogenic HPV types may identify women at the greatest risk of > or = CIN3 and may permit less aggressive management of other women with oncogenic HPV infections...
Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expressionMelissa Rotunno
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
PLoS ONE 4:e5652. 2009..Our findings emphasize the necessity of post-GWAS fine mapping and SNP functional assessment to further elucidate cancer risk associations...
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinomaMaria Teresa Landi
Division of Cancer Epidemiology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Am J Hum Genet 85:679-91. 2009..In conclusion, a lung cancer GWAS identified a distinct hereditary contribution to adenocarcinoma...
Age-related changes of the cervix influence human papillomavirus type distributionPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute NIH, 6120 Executive Boulevard, Bethesda, MD 20892 7234, USA
Cancer Res 66:1218-24. 2006..These patterns need to be confirmed in other studies and populations. We suggest that these genetically distinct groups of HPV types may differ in tissue preferences, which may contribute to their differences in carcinogenic potential...
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samplesJoseph D Carreon
Division of Cancer Epidemiology and Genetics, The National Cancer Institute, National Institutes of Health, Department of Health and Human Services Rockville, Maryland 20852, USA
Int J Gynecol Pathol 26:441-6. 2007..The CIN3 is a substantially more reproducible diagnosis that can be validated more frequently with HPV tests and cytological interpretations than CIN2...
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort studyPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD 20892, USA
BMJ 339:b2569. 2009....
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in OklahomaNicolas Wentzensen
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20854 7234, USA
Int J Cancer 124:964-9. 2009..We are now using these sharpened diagnostic categories to search for novel biomarkers predicting the risk of progression and invasion...
Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanomaPhuong L Mai
Clinical Genetic Branch, National Cancer Institute, Rockville, Maryland, United States of America
PLoS ONE 4:e4812. 2009..Further, possible effect of BRCA mutations on non-cancer mortality risk has not been examined...
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancerPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892 7234, USA
Int J Cancer 125:1649-56. 2009....
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormalityMelinda Butsch Kovacic
Division of Cancer Epidemiology and Genetics and Cancer Prevention Fellowship Program, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
Cancer Res 66:10112-9. 2006..The lack of evident severe abnormalities associated with HPV18 and related HPV types might have implications for screening for poorly detected glandular and alpha7-related lesions...
Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustmentQizhai Li
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Genet Epidemiol 33:432-41. 2009....
Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control studyJill Koshiol
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America
PLoS ONE 4:e7380. 2009..Chronic obstructive pulmonary disease (COPD) has been consistently associated with increased risk of lung cancer. However, previous studies have had limited ability to determine whether the association is due to smoking...
Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancerPhilip E Castle
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 7234, USA
J Infect Dis 203:814-22. 2011..Detailed descriptions of long-term persistence of human papillomavirus (HPV) in the absence of cervical precancer are lacking...
Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3Nicolas Wentzensen
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 5024, Rockville, MD 20852 7234, USA
J Natl Cancer Inst 104:1738-49. 2012..However, the extent of methylation in other HPV types and its role in progression to cancer is poorly understood...
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibilityHong Lou
Laboratory of Experimental Immunology, Cancer and Inflammation Program, National Cancer Institute, Frederick, MD 21702, USA
Proc Natl Acad Sci U S A 106:7933-8. 2009..Further investigation is warranted to determine whether rs10993994 alone or in combination with additional variants contributes to prostate cancer susceptibility...
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical diseaseAnil K Chaturvedi
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072 Rockville, MD 20852, USA
J Infect Dis 203:910-20. 2011..We investigated coinfection patterns for 25 human papillomavirus (HPV) types and assessed the risk conferred by multiple HPV types toward cervical disease...
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysisMark E Sherman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
J Natl Cancer Inst 95:46-52. 2003..We evaluated whether simultaneous screening with a Pap test and human papillomavirus (HPV) testing is useful for assessing the risk for cervical intraepithelial neoplasia (CIN) 3 or cervical cancer...
A population-based study of vaginal human papillomavirus infection in hysterectomized womenPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7234, USA
J Infect Dis 190:458-67. 2004..e., A3/A4/A15) may have a predilection for vaginal epithelium...
Alcohol consumption and lung cancer risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) studyVincenzo Bagnardi
Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, EPS 7114, Bethesda, MD 20892 7236, USA
Am J Epidemiol 171:36-44. 2010..Although residual confounding by tobacco smoking cannot be ruled out, this finding may reflect interplay between alcohol and smoking, emphasizing the need for preventive measures...
Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significanceMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20852, USA
Obstet Gynecol 109:1325-31. 2007....
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa RicaPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892 7234, USA
J Infect Dis 191:1808-16. 2005..In some populations, HPV prevalence demonstrates a second peak in older women. Longitudinal data may help to explain this second peak...
Estimation of effect size distribution from genome-wide association studies and implications for future discoveriesJu Hyun Park
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, Maryland, USA
Nat Genet 42:570-5. 2010..However, for BPC cancers, which have modest familial aggregation, our analysis suggests that risk models based on common variants alone will have modest discriminatory power (63.5% area under curve), even with new discoveries...
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman
Divisions of Cancer Epidemiology and Genetics and Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20852, USA
Cancer Res 70:3159-69. 2010..Larger viral genomic studies are warranted, especially to identify the genetic basis for HPV16's unique carcinogenicity...
Assessing disease risk in genome-wide association studies using family historyArpita Ghosh
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA
Epidemiology 23:616-22. 2012....
Hypertension and risk of renal cell carcinoma among white and black AmericansJoanne S Colt
Division of Cancer Epidemiology and Genetics, Occupational and Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7240, USA
Epidemiology 22:797-804. 2011..We investigated the hypertension-renal cancer association by race, and we assessed the role of hypertension in the racial disparity of renal cancer incidence...
Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotestingSarah Coseo Markt
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
J Infect Dis 205:498-505. 2012..The aim of this analysis was to assess the longitudinal relationship of abnormal cytology and HPV positivity in a 7-year prospective study of 2500 women in Guanacaste, Costa Rica...
Large-scale fine mapping of the HNF1B locus and prostate cancer riskSonja I Berndt
Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7240, USA
Hum Mol Genet 20:3322-9. 2011..This study demonstrates a complex relationship between variants in the HNF1B region and prostate cancer risk. Further studies are needed to investigate the biological basis of the association of variants in 17q12 with prostate cancer...
Human papillomavirus testing in the prevention of cervical cancerMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
J Natl Cancer Inst 103:368-83. 2011..The greatest potential for reduction in cervical cancer rates from HPV screening is in low-resource regions that can implement infrequent rounds of low-cost HPV testing and treatment...
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual lifeAna Cecilia Rodriguez
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Rockville, Maryland 20859, USA
Sex Transm Dis 34:494-502. 2007..We wanted to explore early HPV natural history and CIN 3 prospectively...
Human papillomavirus prevalence in women who have and have not undergone hysterectomiesPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, MD, USA
J Infect Dis 194:1702-5. 2006..5% for WH) between the 2 groups of women. Although WH have a similar prevalence of carcinogenic HPV infection, compared with WNH without a cervix, they have minimal risk of HPV-induced cancer and are unlikely to benefit from HPV testing...
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort StudyMark Schiffman
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 20:1398-409. 2011..Adding HPV testing to cytology is recommended for women ≥30 but long-term prospective studies of HPV testing are rare...
Determinants of seropositivity among HPV-16/18 DNA positive young womenCarolina Porras
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
BMC Infect Dis 10:238. 2010..We evaluated determinants of seropositivity among 646 women infected with HPV-16 and/or HPV-18...
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infectionsMahboobeh Safaeian
Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Ste 550, Rockville, MD 20852, USA
J Natl Cancer Inst 102:1653-62. 2010..Infection with human papillomavirus (HPV) 16 or HPV18 elicits an antibody response, but whether the elicited antibodies protect women against subsequent infection by a homologous HPV type compared with seronegative women is unknown...
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa RicaFelipe A Castro
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 206:1103-10. 2012..Anal cancer is caused by human papillomavirus (HPV), yet little is known about anal HPV infection among healthy young women...
A flexible Bayesian model for studying gene-environment interactionKai Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
PLoS Genet 8:e1002482. 2012....
Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican populationLisa Mirabello
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 6120 Executive Blvd, EPS 7101, Rockville, MD 20892, USA
J Natl Cancer Inst 104:556-65. 2012....
A gene expression signature from peripheral whole blood for stage I lung adenocarcinomaMelissa Rotunno
Division of Cancer Epidemiology and Genetics, NCI, NIH, Department of Health and Human Services, Bethesda, MD 20892, USA
Cancer Prev Res (Phila) 4:1599-608. 2011..81, 95% CI = 0.74-0.87). Our finding suggests the use of gene expression from PWB for the identification of early detection markers of lung cancer in the future...
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine TrialAimee R Kreimer
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Lancet Oncol 12:862-70. 2011..Human papillomavirus (HPV) 16 and 18 infections cause most cases of anal cancer. We assessed efficacy of an AS04-adjuvanted HPV 16 and HPV 18 vaccine against anal infection with HPV 16, HPV 18, or both (HPV 16/18)...
Family history of cancer and nonmalignant lung diseases as risk factors for lung cancerYing Gao
Division of Cancer Epidemiology and Genetics, Genetic Epidemiology Branch, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892 7236, USA
Int J Cancer 125:146-52. 2009..23-1.80) and decreased (OR = 0.73, 95% CI = 0.61-0.87) lung cancer risk, respectively. FH of lung cancer and nonmalignant lung diseases affected lung cancer risk independently, and did not appear to be modified by FH of smoking...
Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer riskTram Kim Lam
Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Carcinogenesis 31:634-42. 2010..Our findings suggest an interplay between quercetin intake, tobacco smoking, and lung cancer risk. Further research on this relationship is warranted...
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancerPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
J Clin Microbiol 41:4022-30. 2003..68 to 0.79). In conclusion, we suggest that HC3 (>/=0.6 RLU/PC) may be slightly more sensitive than and equally specific test as HC2 (>/=1.0 RLU/PC) for the detection of CIN3+ over the duration of typical screening intervals...
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccineAimee R Kreimer
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7084, Rockville, MD 20852, USA
J Natl Cancer Inst 103:1444-51. 2011..Three-dose regimens for human papillomavirus (HPV) vaccines are expensive and difficult to complete, especially in settings where the need for cervical cancer prevention is greatest...
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 diseaseAimee R Kreimer
National Cancer Institute, NIH, 6130 Executive Boulevard, Bethesda, MD 20892 7333, USA
Cancer Epidemiol Biomarkers Prev 15:908-14. 2006....
Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasiaLisa Mirabello
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
Int J Cancer 132:1412-22. 2013..Higher methylation in CIN2+ cases was not explained by higher viral load. We conclude that elevated levels of HPV16 DNA methylation may be useful to predict concurrently diagnosed as well as future CIN2+...
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestryZhaoming Wang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
Hum Genet 131:1173-85. 2012....
The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategiesJulia C Gage
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, DHHS, Bethesda, MD, USA
Int J Cancer 130:2111-7. 2012....
A large, population-based study of age-related associations between vaginal pH and human papillomavirus infectionMegan A Clarke
Division of Cancer Epidemiology and Genetics, DHHS, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
BMC Infect Dis 12:33. 2012..We examined vaginal pH and the risk of HPV infection, cytological abnormalities, and C. trachomatis infection...
Multiple loci identified in a genome-wide association study of prostate cancerGilles Thomas
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
Nat Genet 40:310-5. 2008..Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals...
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancerCharles C Chung
Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute NIH, 8717 Grovemont Circle, Bethesda, MD 20892, USA
Hum Mol Genet 20:2869-78. 2011..We estimate that at least 63 common variants should be considered in future studies designed to investigate the biological basis of the multiple association signals...
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus typesPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA
Cancer Epidemiol Biomarkers Prev 11:1394-9. 2002....
Invited commentary: efficient testing of gene-environment interactionNilanjan Chatterjee
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, Department of Health and Human Services, Bethesda, Maryland, USA
Am J Epidemiol 169:231-3; discussion 234-5. 2009..The development of new approaches to testing for interaction is an example of methodological progress leading to practical advantages...
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History StudyNicolas Wentzensen
National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 204:94-102. 2011..A competitive Luminex Immunoassay (cLIA) has been developed to measure neutralizing antibodies against human papillomavirus (HPV) types 6, 11, 16 and 18...
Influence of loop electrosurgical excision procedure on subsequent acquisition of new human papillomavirus infectionsPhilip E Castle
Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
J Infect Dis 199:1612-20. 2009..The impact of loop electrosurgical excision procedure (LEEP) treatment for cervical precancerous lesions on subsequent acquisition of new human papillomavirus (HPV) infections is not well described...
BRCA1 and sex ratioJeffery P Struewing
Laboratory of Population Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 5060, USA
Eur J Hum Genet 12:663-7. 2004..Nonetheless, these observations do not support the idea that BRCA1 mutation carriers have a lower ratio of male offspring than BRCA2 mutation carriers...
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892 7234, USA
J Natl Cancer Inst 97:147-50. 2005..The minimal increases in sensitivity and in negative predictive value achieved by adding HPV types to DNA tests must be weighed against the projected burden to thousands of women falsely labeled as being at high risk of cervical cancer...
PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infectionPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Room 7074, 6120 Executive Boulevard, EPS MSC 7234, Bethesda, MD 20892 7234, USA
Cancer Epidemiol Biomarkers Prev 14:256-60. 2005..3% (95% CI, 74.7-91.4%), respectively. We conclude that pooling specimens and testing by PCR may be useful for discriminating HPV DNA-positive from completely negative specimen sets in women who are likely to have been HPV DNA-negative.>..
Bias in intervention studies that enroll patients from high-risk clinicsSholom Wacholder
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7244, USA
J Natl Cancer Inst 96:1204-7. 2004....
Improved genetic association tests for an ordinal outcome representing the disease progression processHong Zhang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Bethesda, MD 20892, USA
Genet Epidemiol 35:499-505. 2011..As a demonstration, we applied the considered tests to a genetic association study of cervical cancer...
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative womenPhilip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA
Cancer 95:2145-51. 2002..The absolute risk of a subsequent abnormal Pap test for these women is uncertain. Therefore, the proper counseling and clinical management of these women is also uncertain...
Assessment of human papillomavirus in lung tumor tissueJill Koshiol
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7248, USA
J Natl Cancer Inst 103:501-7. 2011..Lung cancer kills more than 1 million people worldwide each year. Whereas several human papillomavirus (HPV)-associated cancers have been identified, the role of HPV in lung carcinogenesis remains controversial...
Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformationsElizabeth M Azzato
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Rockville, Maryland 20852, USA
Pharmacogenet Genomics 20:58-63. 2010....
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsNicolas Wentzensen
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852 7234, USA
Int J Cancer 125:2151-8. 2009..The potential range of HPV genotype attribution is wide at the disease categories <CIN2 to CIN3. Genotyping from cervical lesions and analyzing viral oncogene expression can improve estimates of HPV genotype attribution...
Population substructure and control selection in genome-wide association studiesKai Yu
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America
PLoS ONE 3:e2551. 2008..A study using suboptimal controls can have acceptable type I error when an effective strategy for the correction of PS is employed...
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa RicaSarah Coseo
Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd, EPS, Room 7079, Rockville, MD 20852, USA
Sex Transm Dis 37:706-14. 2010..We investigated HPV16 and 18 seroepidemiology among young, unvaccinated women aged between 18 and 25...
Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactionsNilanjan Chatterjee
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
Am J Hum Genet 79:1002-16. 2006....
Human papillomavirus genotype specificity of hybrid capture 2Philip E Castle
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd, Room 5030, EPS MSC 7234, Bethesda, MD 20892 7234, USA
J Clin Microbiol 46:2595-604. 2008..In conclusion, hc2 cross-reacts with certain untargeted, noncarcinogenic HPV genotypes that are phylogenetically related to the targeted genotypes, but the degree of cross-reactivity may be less than previously reported...
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7246, USA
J Natl Cancer Inst 95:1072-8. 2003..We assessed the level and persistence of reduction of ovarian (including peritoneal) cancer risk after gynecologic surgeries for women who carry BRCA1/2 mutations but were not selected from high-risk clinics...
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalMaria Teresa Landi
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health NIH, Department of Health and Human Services DHHS, Bethesda, Maryland, USA
PLoS ONE 3:e1651. 2008..Tobacco smoking is responsible for over 90% of lung cancer cases, and yet the precise molecular alterations induced by smoking in lung that develop into cancer and impact survival have remained obscure...
Genetic variations in CC chemokine receptors and hypertensionMingdong Zhang
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH DHHS, 6120 Executive Boulevard, Rm 7082, MSC 7234, Rockville, MD 20852, USA
Am J Hypertens 19:67-72. 2006..The present study was carried out to verify these associations...
Joint effect of genes and environment distorted by selection biases: implications for hospital-based case-control studiesSholom Wacholder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 20892-7244, USA
Cancer Epidemiol Biomarkers Prev 11:885-9. 2002..This formulation extends to the general problem of distortion of joint effects from selection biases or confounding...
Interpreting epidemiologic research: lessons from studies of childhood cancerMartha S Linet
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892-7238, USA
Pediatrics 112:218-32. 2003
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected womenPhilip E Castle
National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD 20892, USA
J Natl Cancer Inst 94:1406-14. 2002..However, these potential risk factors have not been adequately studied in prospective studies...
One gene and one outcome? No wayStephen Chanock
Section on Genomic Variation, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Trends Mol Med 8:266-9. 2002..The challenge lies in sorting through the information and developing effective strategies to advance molecular diagnostics...
Interobserver agreement in the evaluation of digitized cervical imagesJose Jeronimo
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20852, USA
Obstet Gynecol 110:833-40. 2007..To estimate the agreement among multiple expert colposcopists evaluating high-resolution digitized cervigrams taken from patients with a variety of human papillomavirus (HPV) infection states and previous cervigram interpretations...
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trialAllan Hildesheim
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
JAMA 298:743-53. 2007..Viruslike particle human papillomavirus (HPV) vaccines were designed to prevent HPV infection and development of cervical precancers and cancer. Women with oncogenic HPV infections might consider vaccination as therapy...
The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MA, USA
Virology 337:76-84. 2005..These results present several clear clues and research directions in our ongoing efforts to understand HPV carcinogenesis...
Quantifying epidemiologic risk factors using non-parametric regression: model selection remains the greatest challengePhilip S Rosenberg
National Cancer Institute, Division of Cancer Epidemiology and Genetics, Biostatistics Branch, 6120 Executive Boulevard, EPS 7006, Rockville, MD 20852, USA
Stat Med 22:3369-81. 2003..Nonetheless, the semi-parametric approach appears to be a practical advance...
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive historyPatricia Hartge
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892 7246, USA
Epidemiology 13:255-61. 2002..Younger age at first birth and greater parity generally reduce the risk of developing breast cancer, but whether this reduced risk holds in women with a mutation in the BRCA1 or BRCA2 gene is unknown...
Response rates in a case-control study: effect of disclosure of biologic sample collection in the initial contact letterJoanne S Colt
Occupational Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20852, USA
Ann Epidemiol 15:700-4. 2005..In a population-based case-control study of kidney cancer involving an interview and optional biospecimens, we examined whether mentioning the biospecimens in the initial contact letter adversely affects willingness to be interviewed...
The impact of a prevention effort on the communitySholom Wacholder
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892 7244, USA
Epidemiology 16:1-3. 2005..For example, ACR provides a useful comparison of the potential benefits of efforts to prevent breast cancer and to prevent ovarian cancer among women with a BRCA1 or BRCA2 mutation...
CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese womenXiaohong R Yang
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd, Bethesda MD 20892, USA
Cancer Lett 214:197-204. 2004..In summary, our case-control study of lung cancer among women in northeast China revealed an elevated risk associated with the CYP1A1 I462V genotype, but no interaction with smoking or indoor air pollution was found...
Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2Ludmila Prokunina-Olsson
Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, 8717 Grovemont Circle, Bethesda, MD 20892 4605, USA
Cancer Epidemiol Biomarkers Prev 19:1349-55. 2010..2, showed a promising association with PrCa overall (P=2.14x10(-6)), with a suggestion of stronger association with aggressive disease (P=1.2x10(-7))...
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph ConsortiumNathaniel Rothman
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
Lancet Oncol 7:27-38. 2006..We aimed to test this hypothesis using previously unpublished data from eight European, Canadian, and US case-control studies of the International Lymphoma Epidemiology Consortium (InterLymph)...
Lower risk of lung cancer after multiple pneumonia diagnosesJill Koshiol
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Boulevard, MSC 7248, Bethesda, MD 20892 7248, USA
Cancer Epidemiol Biomarkers Prev 19:716-21. 2010..Although pneumonia has been suggested as a risk factor for lung cancer, previous studies have not evaluated the influence of number of pneumonia diagnoses in relation to lung cancer risk...
Assessing the probability that a positive report is false: an approach for molecular epidemiology studiesSholom Wacholder
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7244, USA
J Natl Cancer Inst 96:434-42. 2004..An FPRP-based criterion for deciding whether to call a finding noteworthy formalizes the process already used informally by investigators--that is, tempering enthusiasm for remarkable study findings with considerations of plausibility...
Maternal sensitivity concerning aetiological research into childhood cancer: results of preliminary focus groupsMartha S Linet
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Baethesda, MD 20892 7238, USA
Paediatr Perinat Epidemiol 21:169-78. 2007..We conclude that the focus group approach can contribute to a broad strategy for improving questionnaires and methods for conducting paediatric cancer epidemiological research...
The HER2 I655V polymorphism and breast cancer risk in AshkenazimJoni L Rutter
Laboratory of Population Genetics, Center for Cancer Research, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
Epidemiology 14:694-700. 2003..CONCLUSION These analyses suggest that the HER2 valine allele might be associated with increased risk of breast cancer, especially in young women and in women with a family history of the disease...
